Curriculum Vitae
Name: Lara Bellocchio
IT - 06042 Campello sul Clitunno
e-mail :
Personal website:
Education :
- I obtained my first degree in 1991 in translation at European Institute for Translators and Interpreters in Perugia (IT).
- I pursued my second degree in 2006 in Sciences of Linguistic Mediation at the University Institute of Linguistic Mediation in Perugia (IT).
Courses:
Post-graduate Certificate of Academic Course in Grammar and Conversation - Florida International University – English Language Institute (ELI).
Language pair :
English > Italian
French > Italian
Rates :
Min 0.06 – Max 0.10. Rates depend on subject matter, timing, volume.
Presentation:
At present I work as translator freelance worldwide.
From 2001 to 2007 I have been working as professor assistant at the Faculty of Medicine of the University of Perugia (IT).
Among my assignments have been:
1. Reviewing and proofreading of scientific articles published in journal such as Blood, Nature etc. (see publications list below)
2. Proofreading, editing and translation of book chapters and reviews.
3. Translation of accountability docs in government administration and management databases.
4. Conducting follow-up reviews, drafting and translation of National and European Union projects.
5. Translation of Power point presentations for medical congress, seminars and lessons.
6. Web content translation.
From 2006 to 2007 I have been freelance translator for Biotechnology Industry:
1. Translation of contracts and instrument manuals for Roche Diagnostics.
2. Software localization , translation of diagnostic procedures and medical devices manuals for Biomerieux.
Years 2003, 2004, 2006-2007 Professional collaboration
Sigma Tau – Industrie Farmaceutiche Riunite S.p.a. – Pharmaceutics Industry
1. Management, drafting, translation and proofreading of R&D EU scientific projects (Cordis).
2. Scientific data processing, clinical trial, drawing up of reports, tables, editorial assistance for scientific articles (editing, graphic layout, bibliography, translation and proof-reading).
From 2007 to 2008 I have been on the staff of a Cultural Institution (Theatre) , taking care of press release, web content translation, translation of contracts with European and international cultural institutions and foreign artists, translation of documents for public administration and local government, general content reports. Drafting and translation of EU culture projects (EACEA).
From 2010 I have translated for USA companies medical and pharma datasheets. I have also translated Microsoft applications user guide.
In 2010 I was consultant at Umbria Traning Center-UTC drafting, translating EU Life Long Learning projects. I also took care of the whole submission procedure to the Commission.
Congress attending:
“European Community: VII Framework Programme on Research and Technological Development”. APRE. University of Perugia, Perugia, Italy, June 29, 2006.Attending certificate.
“Living and Working in United Kingdom”. Regione Umbria - Servizio Politiche Attive del Lavoro. EURES. Perugia 28 October, 2009, Italy. Attending certificate.
Expertise:
Thanks to the several filed of application I have gained expertise in many topics, among them an excellent knowledge of EU policy terminology.
Manuals: Translation of manuals: medical device; diagnostic procedures, localization software. Industrial and mechanical equipment.
Scientific translations and proof-reading:Scientific articles, congress presentations, abstracts, conference proceedings, medical datasheets.
Other fields:
Web content examples: (culture); (electronic components); (nautical).
Journalism : I have worked 3 years as journalist freelance in a magazine gaining experience in the field of social sciences, politics and culture.
Advertising and marketing translations:Brochures, leaflets, catalogues for local industries
Commercial translations:Business correspondence, agreements, contracts
Law and Financial: contractual licenses, membership rules, terms of reference and service contracts, legal acts.
Mechanical manuals: fork lift manual, equipments.
Classic texts:
- Translation of Henry James' short novel : Daisy Miller
- Translation of the civil proceedings (Indictment, Defence and Sentence) against Gustave Flaubert and his novel Madame Bovary.
Operating system on PC: Windows XP
Software: Office 2007; Adobe Acrobat; Adobe Reader, Nuance PDF 6.Graphic Suite CorelDraw 12; Adobe Photoshop; Windows Movie Maker; Corel Ventura 7.
Other software: Endnote 9. Bibliography and manuscript maker. Online search tool for storing, managing, and searching bibliographic references using RTF Document Scan for compatibility with word processors;
CAT tools: Trados freelance 7; Wordfast Pro, Wordfast Anywhere, SDLX2007, Idiom, Passolo, Across.
Management of EU research projects:
1. Research project ofItalian Public Health Institute (I.S.S.). National Program on AIDS.
2. Consortium Agreement for Specific Targeted Research under the Sixth Framework Programme of the European Community for the Project.
3. Research project between the Italian Public Health Institute - I.S.S. and National Institute of Allergy and Infectious Diseases - NIAID, NIH – USA.
4. Specific Targeted Research or Innovation Project under the Sixth Framework Programme on Research, Technological Development and Demonstration of the European Community for the projects.
5. Research programmes under the Seventh Framework Programme of the European Community in the field Cooperation – Theme: Health. Period: 2007-2013
6. Programmes in culture field (EACEA). Period: 2007-2013.A
Acknowledgements for editorial assistance in book chapters
Chapter 16. Cytokines in the innate and adaptive immunity to Candida albicans. In: “Cytokines and Chemokines in Infectious Diseases Handbook”, Eds. Kotb M. & Calandra T., Humana Press Inc., pp. 227-241, 2003.
Chapter 5. Innate Immunity to Fungi: The Art of Speed and Specificity. In: Pathogenic Fungi, Eds San-Blas G., Calderone R.A., Caister Academic Press, Wymondham, Norfolk, UK, pp 167-214, 2004.
Chapter 44. Dendritic cells in immunity and vaccination against fungi. In Handbook of Dendritic Cells. Biology, Diseases and Therapies, 2 vol. Eds. Lutz M.B. and Steinkasserer A. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2006. pp. 915-930.
Chapter 32. Innate and Acquired Cellular Immunity to Fungi. In Molecular Principles of Fungal Pathogenesis. Eds. Heitman J., Filler S., Edwards J. and Mitchell A., ASM Press, Washington D.C. 2006. pp. 471-486.
Systemic Immunity in Candidiasis. In: Fungal Pathogensis: Principles and Clinical Applications. Eds Calderone R. and Chilan R.L., Marcek Dekker , New York , NY , pp. 483-514, 2001.
  1. Innate Immunity against Fungal Pathogens. In: Fungal Pathogensis: Principles and Clinical Applications. Eds Calderone R. and Chilan R.L., Marcek Dekker , New York , NY , pp. 401-432, 2001.
  2. The innate and adaptive immunity to Candida albicans. In: Fungal Immunology, Eds Fidel P., Huffnagle G., Kluwer Academic/Plenum Publishers, 2004.
  3. Dendritic cells in immunity and vaccination against fungi. In Handbook of Dendritic Cells. Biology, Diseases and Therapies, 2 vol. Eds. Lutz M.B. and Steinkasserer A. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2006. pp. 915-930.
  4. Innate and Acquired Cellular Immunità to Fungi. In Molecular Principles of Fungal Pathogenesis. Eds. Heitman J., Filler S., Edwards J. and Mitchell A., ASM Press, Washington D.C. 2006. pp. 471-486.
  5. Dendritic cells. In: Immunology of fungal infections. Eds. Springer, 2006.
Acknowledgements for editorial assistance in scientific articles
  1. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J. Infect. Dis. 184: 610-617, 2001.
  2. Host immunity reactivity and antifungal chemotherapy: the power of being together. J. Chemotherapy 13: 347-353, 2001.
  3. The plasticity of dendritic cells at the host/fungal interface. Proceding of 3° Berlin Symposium on Immunology of Infection 24-27 April 2001 Immunobiology. 204: 582-589, 2001.
  4. Protection of killer antidiotypes against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation. Infect. Immun. 70: 2375-2382, 2002.
  5. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus J. Immunol. 168: 1362-1371, 2002.
  6. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J. Immunol. 168: 2904-2913, 2002.
  7. The interaction of Fungi with dendritic cells: implications for Th immunity and vaccination. Curr. Molecular Med. 2:485-505, 2002.
  8. “B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory protective immunity to Candida albicans”. J. Immunol. 169:6298-6308, 2002.
  9. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 10:508-514, 2002.
  10. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect. 4:1281-1290, 2002.
  11. A role for antibodies in the generation of memory antifungal immunity. Eur J Immunol. 2003, 3: 1193-1204.
  12. Adaptation of Candida albicans to the host envitonment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr. Opin. Microbiol. 6: 338-343, 2003.
  13. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102: 3807-3814, 2003.
  14. The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int. Immunol. 16: 149-161, 2004.
  15. Immunity to fungal infections. Nat. Rev. Immunol. 4: 11-23 Review, 2004.
  16. Dendritic cell-based vaccination against opportunistic fungi. Vaccine 22: 857-864, 2004.
  17. The contribution of the toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol. 172: 3059-3069, 2004.
  18. Thymosin 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling. Blood. 103: 4232-4239, 2004.
  19. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother. 2004, 48:4414-21.
  20. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med Mycol. 2004, 42:319-324.
  21. Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation. Blood Cells, Molecules, and Diseases 2004, 33:248-255.
  22. Local immune reactivity in fungal nasal polyposis. Infect. Immun. 2004, 72:7275-7281.
  23. TLRs Govern Neutrophil Activity in Aspergillosis. J. Immunol. 2004, 173:7406-15.
  24. Liposomal Amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signaling from TLR-2 to TLR-4. J Antimicrob Chemother. 2005, 55:214-22.
  25. A Crucial Role for Tryptophan Catabolism at the Host/Candida albicans Interface. J Immunol. 2005, 174:2910-8.
  26. Immunity to Aspergillus fumigatus: the bases for immunotherapy and vaccination. Proceeding Advances Against Aspergillosis, Sptember 8-11, 2004, San Francisco. Med Mycol. 43:S181-S188, 2005.
  27. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood. 106:4397-4406, 2005.
  28. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176:1712-1723, 2006.
  29. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol. 14:183-189, 2006.
  30. Manipulating immunity against Aspergillus fumigatus. Med. Mycol. 44: 237-243, 2006.
  31. Thymosin 1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood. 108:2265-74, 2006.
  32. Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood. 108:3387-96, 2006.
  33. Candida albicans allergenic extract induces toll-like receptor expression and increases interferon-alpha production. Pediatr Dermatol. 23:517-8, 2006.
  34. Immunity and tolerance to Aspergillus fumigatus. Novartis Found Symp. (discussion 77-9, 216-9) 279:66-77, 2006.
  35. Receptors and pathways in innate antifungal immunity: the implication for tolerance and immunity to fungi. Adv Exp Med Biol. 590:209-21, 2007.

Congress activity

During my activity I have also gained a huge experience in using word processing, power point presentations and spreadsheet and graphic software (editing, layout, bibliographic researches, translations, proof-reading).
International Congress:
  1. 3rd Berlin Symposium on immunology of Infection “Dendritic Cells and Macrophages in Infectious Diseases”, Berlin: 25-27 May, 2001.
  2. Keystone Symposia on “Dendritic Cells: Interfaces with Immunobiology and Medicine”, Taos, New Mexico, 12-18 March, 2001.
  3. Dendritic Cells at the Host-Pathogen Interface, Warrenton, VA, 4-7 May, 2002.
  4. 102nd General Meeting, American Society for Microbiology, Salt Lake City, Utah, 19-23 May, 2002.
  5. 6th ASM Conferences on “Candida and Candidiasis”, Tampa, Florida, 13-17 January, 2002.
  6. 7th Kongress fur Infektionskrankheiten und Tropenmedizin, Berlin, 27 February – 1 March, 2003.
  7. 15th Congress of the International Society for Human and Animal Mycology, San Antonio, Texas, 25-29 May, 2003.
  8. 17th seminar – Possibilities for active and passive vaccination against opportunistic infections. Hohe schule, herborn-Dill, Germany, 23rd June, 2003.
  9. Klinikum der Universitat Munchen. Munchen, Germany, May 26, 2004.
  10. Biology of host-parasite interactions. Gordon Research Conference. Newport, RI, June 27 – July 2, 2004.
  11. Advances Against Aspergillosis. San Francisco, USA, September 9-11, 2004.
  12. 42nd Annual Meeting of IDSA. Boston, USA, September 30, 2004.
  13. Department of Microbiology and Division of Infectious Disease research Seminar Series. Boston University School of Medicine. Boston, USA, October 4, 2004.
  14. 3rd International Conference on Innate Immunity. Aegean Conferences. Crete, Greece, October 10-15, 2004.
  15. 44th Annual ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy). Washington, DC, USA, October 30 – November 2, 2004.
  16. Poster session 352-II, Experimental Transplantation – Stem Cell Biology. Abstract 2139 appeared in Blood 2004, vol. 104, issue 11. San Diego, USA, December 5, 2004.
  17. FEBS Advanced Lecture Course. Human Fungal Pathogens – Molecular Mechanisms of Host-Pathogen Interactions and Virulence. La Colle-sur-Loup, France, May 21-28, 2005.
  18. IUMS, XI International Congress of Mycology. San Francisco, California, July 23-28, 2005.
  19. IX International Meeting on Paracoccidioidomycosis. Sao Paulo, Brasil, October 2-5, 2005.
  20. ALAI. VII Congreso Latinoamericano de Inmunologia. Còrdoba, Argentina, October 2-6, 2005.
  21. Aegean Conference. Rhodes – Greece, October 9-14, 2005.
  22. International Postgraduate Programme 2005. University of Minho. Braga, Portugal. October 27-29, 2005.
  23. “Innate Immunity to Pulmonary Infection.”Novartis Foundation Symposium 279. Cape Town, South Africa, November 27-30, 2005.
  24. “Innate Immunity in the Lung”, EMBO. Cape Town, South Africa, November 30, 2005.
  25. “2nd Advances Against Aspergillosis.”Athens, Greece, February 22-25, 2006.
  26. 8th ASM Conference on Candida and Candidiasis. Denver, Colorado, March 13-17, 2006.
  27. Annual congress SGAI-SSAI. Swiss Society for Allergology and Immunology. Zurich, Swiss, March 30-31, 2006.
National Congress:
  1. Congress “Diagnosi e Terapia delle Infezioni Fungine”. Ospedale Santo Spirito, Rome, Italy, June 14, 2002.
  2. Educational training, Immunologia e percorsi diagnostici delle infezioni fungine. Ospedale S. Giovanni Addolorata. Rome, Italy, October 30, 2002.
  3. 5th Meeting New Insights in Hematology and 1st Nurses Meeting, Venice, Italy, May 15-18, 2003.
  4. 2nd Congresso Nazionale Diagnostica e Terapia delle Micosi Opportunistiche, Genova, Italy, June 26-28, 2003.
  5. Novità e prospettive in tema di infezioni da funghi nel paziente immunocompromesso. Ospedale SS. Annunziata, Taranto, Italy, September 24, 2003.
  6. 39° Congresso Nazionale SIE, Rome, Italy, October 26-29, 2003.
  7. Ist. di malattie infettive e tropicali. Az. Osp. Polo Universitario “Luigi Sacco”. Milan, Italy, November 2003.
  8. Toll 2004. Taormina, Sicily, Italy, May 8-11,2004.
  9. International PhD. Program in Molecular Medicine. Basic and Applied Immunology. Istituto Mario Negri, Milan, Italy, May 24, 2004.
  10. Corso di aggiornamento. Management delle infezioni fungine nel paziente critico. Cagliari, Italy, June 4, 2004.
  11. Fourth International Workshop on Haploidentical Transplants. Naples, Italy, July 8-10, 2004.
  12. Seminar. Sigma Tau SpA, Rome, Italy, May 12, 2004.
  13. 3rd National Conference SIICA, Ischia, Italy, April 24-27, 2004.
  14. Stage in Oncologia, Istituto di Ematologia e Oncologia Medica, L. e A. Seragnoli. Bologna, Italy, June 21-23, 2004.
  15. 12th National Congress of Italian Society of Medical and Clinical Microbiology (SIMMOC). Genova, Italy, June 20-22, 2004.
  16. 7th Annual Meeting. Tuscany Critical Care Group. Siena, Italy, Semptember 23-25, 2004.
  17. 32° Congresso Nazionale Società Italiana di Microbiologia. Milan, Italy, September 26-29, 2004.
  18. Corso ECM Perugia, Infezioni fungine in ematologia e in terapia intensiva. Perugia, Italy, October 22, 2004.
  19. Infezioni in Ematologia. Bologna, Italy, October 23, 2004.
  20. FIMUA. Giornata Studio: La terapia antifungina, dieci anni dopo. Otranto (LE). May 28, 2005.
  21. 3° Congresso Nazionale, Diagnostica e Terapia delle Micosi Opportunistiche. Genova, Italy, June 23-25, 2005.
  22. 40° Congresso Nazionale. SIE, Società Italiana di Ematologia. Simposio Gilead Sciences. Bergamo, July 3-6, 2005
  23. Congresso Gilead. Villasimius, Cagliari, September 2005.
  24. II Workshop su: Le infezioni micotiche invasive nel paziente ematologico e trapiantato di midollo. Bologna, October 8, 2005.
  25. 33° Congresso Nazionale Società Italiana di Microbiologia. Naples, October 16-19, 2005.
  26. Congresso “Attualità in tema di terapia: tra nuove acquisizioni biologiche ed implicazioni terapeutiche.”Modena, November 16, 2005.
  27. Congresso “Infezioni fungine disseminate: dagli studi clinici all’assistenza del paziente.”Torino, November 18, 2005.
  28. Corsi teorico-pratici di perfezionamento in diagnostica micologica. FIMUA, Federazione Italiana Micopatologia Umana ed Animale. Catania, Italy, February 16-18, 2006.
  29. 1st Workshop on: Bone Marrow Transplantation in Thalassemia. University of Tor Vergata, Rome, Italy, March 27-31, 2006.
  30. Workshop: Aspergillosi invasiva nel paziente ematologico e trapiantato: evidenze ed esperienze a confronto. Perugia, Italy, May 5, 2006.
  31. 14° Congresso Nazionale, S.I.M.M.O.C. Perugia, Italy, May 10-11, 2006.
  32. Primo corso di aggiornamento. Azienda Ospedaliera “D. Cotogno”, Naples, Italy, June 16, 2006.
  33. 34° Congresso Nazionale della Società Italiana di Microbiologia. FIMUA. Genova, Italy, October 15-18, 2006.

December, 2010
Lara Bellocchio

1